 | Up a level |
Colombo, Ilaria; Koster, Kira-Lee; Holer, Lisa; Haefliger, Simon; Rabaglio, Manuela; Bastian, Sara; Schwitter, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Mc Laughlin, Anna M; Kloft, Charlotte; Klose, Marian; Halbherr, Stefan; Baumgartner, Christian; Sessa, Cristiana; Stathis, Anastasios; Hess, Dagmar; Joerger, Markus (2024). TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16). European journal of cancer, 201(113588), p. 113588. Elsevier 10.1016/j.ejca.2024.113588
Ahlers, Joachim; Baumgartner, Christian; Augsburger, Mareike; Wenger, Andreas; Malischnig, Doris; Boumparis, Nikolaos; Berger, Thomas; Stark, Lars; Ebert, David D; Haug, Severin; Schaub, Michael P (2022). Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis. Journal of medical internet research, 24(4), e30138. Centre of Global eHealth Innovation 10.2196/30138
Baumgartner, Christian; Schaub, Michael Patrick; Wenger, Andreas; Malischnig, Doris; Augsburger, Mareike; Walter, Marc; Berger, Thomas; Stark, Lars; Ebert, David Daniel; Keough, Matthew T; Haug, Severin (2021). CANreduce 2.0 Adherence-Focused Guidance for Internet Self-Help Among Cannabis Users: Three-Arm Randomized Controlled Trial. Journal of medical internet research, 23(4), e27463. JMIR Publications 10.2196/27463
Amann, Manuel; Haug, Severin; Wenger, Andreas; Baumgartner, Christian; Ebert, David D; Berger, Thomas; Stark, Lars; Walter, Marc; Schaub, Michael P (2018). The Effects of Social Presence on Adherence-Focused Guidance in Problematic Cannabis Users: Protocol for the CANreduce 2.0 Randomized Controlled Trial. JMIR research protocols, 7(1), e30. JMIR Publications 10.2196/resprot.9484
